Characterization of the human immune response to the UK anthrax vaccine
Open Access
- 1 October 2004
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 42 (2) , 267-270
- https://doi.org/10.1016/j.femsim.2004.05.011
Abstract
The anthrax bipartite lethal toxin (protective antigen (PA) and lethal factor (LF))-specific antibody responses of humans receiving the UK licensed aKeywords
This publication has 16 references indexed in Scilit:
- Impairment of dendritic cells and adaptive immunity by anthrax lethal toxinNature, 2003
- Characterisation of the immune response to the UK human anthrax vaccineFEMS Immunology & Medical Microbiology, 2003
- In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibodyJournal of Medical Microbiology, 2002
- The development of new vaccines against Bacillus anthracisJournal of Applied Microbiology, 2001
- Protection against Anthrax Lethal Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal Factor ProteinInfection and Immunity, 2001
- The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax sporesMicrobiology, 2001
- Search for Correlates of Protective Immunity Conferred by Anthrax VaccineInfection and Immunity, 2001
- Role of Toxin Functional Domains in Anthrax PathogenesisInfection and Immunity, 2000
- Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracisLetters in Applied Microbiology, 1998
- THE USE OF ANTHRAX ANTIGEN TO IMMUNISE MAN AND MONKEYThe Lancet, 1956